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Background: The optimal grafting strategy during CABG is not clear beyond the LITA-LAD graft. We compared late survival in patients receiving 
either the radial artery (RA), right internal thoracic artery (RITA) or saphenous vein (SVG) as the preferred second graft.
methods: Late survival data was collected for 13,130 consecutive LITA-LAD patients (65±10 yrs; 71% male; 4540 RA, 1643 RITA and 6947 SVG) 
from three hospitals. Early death (n=194, 1.4%) and RA+RITA patients were excluded. Propensity matching was used to obtain 1301 RA/RITA/SVG 
matched triplets (Total N = 3903) analyzed by Kaplan Meier analysis. Cox regression analysis was performed on all patients.
results: The matched triplets comparison showed superior late RA survival compared to SV (P<0.001) and to RITA (P<0.001), while the RITA 
and SVG groups showed similar survival overall.[Fig-Left] Comprehensive risk-adjustment via Cox regression confirmed the matched results, and 
demonstrated relatively superior RA vs. SVG survival irrespective of age.[Fig-Right] There was a RITA vs SVG advantage only in patients ≤65 yrs [RR 
(95% CI) = 0.74 (0.61-0.89)] and no difference in RA vs RITA survival across all ages.
conclusions: RA as a second arterial graft vs SVG is associated with improved late survival in all patients and especially in those <70 yrs. The RITA 
vs SVG survival benefit is primarily in patients ≤65 yrs. The optimal grafting strategy during CABG is either a RA or RITA in addition to the LITA-LAD 
graft in younger patients and a RA in older patients.
 
